We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
-4.8%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$6.53B
AUM Growth
-$743M
Cap. Flow
-$221M
Cap. Flow %
-3.38%
Top 10 Hldgs %
12.1%
Holding
647
New
71
Increased
143
Reduced
319
Closed
74

Top Buys

Rank Stock Value
1
SYNA icon
Synaptics
SYNA
+$36.2M
2
ALGM icon
Allegro MicroSystems
ALGM
+$32.7M
3
AMBA icon
Ambarella
AMBA
+$21.2M
4
ATR icon
AptarGroup
ATR
+$20.4M
5
FIVN icon
FIVE9
FIVN
+$20.1M

Sector Composition

Rank Sector Weight
1 Technology 18.14%
2 Industrials 17.3%
3 Financials 15.66%
4 Healthcare 14.96%
5 Consumer Discretionary 11.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SITM icon
276
SiTime
SITM
$16.4B
$6.56M 0.1%
42,932
-1,210
-3% -$232K
ECG
277
Everus Construction Group
ECG
$7.1B
$6.55M 0.1%
+176,605
New +$9.51M
MAS icon
278
Masco
MAS
$15.3B
$6.43M 0.1%
92,424
+12,347
+15% +$924K
LMAT icon
279
LeMaitre Vascular
LMAT
$1.87B
$6.41M 0.1%
76,460
+17,354
+29% +$1.61M
OUT icon
280
Outfront Media
OUT
$5.66B
$6.28M 0.1%
389,261
-6,534
-2% -$117K
COCO icon
281
Vita Coco
COCO
$3.81B
$6.15M 0.09%
200,509
-5,652
-3% -$202K
JNJ icon
282
Johnson & Johnson
JNJ
$623B
$6.04M 0.09%
36,403
-267
-0.7% -$41.8K
CSW
283
CSW Industrials
CSW
$5.62B
$6.01M 0.09%
20,617
-582
-3% -$189K
BBCA icon
284
JPMorgan BetaBuilders Canada ETF
BBCA
$11.1B
$5.99M 0.09%
83,673
-10,408
-11% -$750K
ALGT icon
285
Allegiant Air
ALGT
$2.87B
$5.96M 0.09%
115,367
+7,432
+7% +$597K
IBM icon
286
IBM
IBM
$224B
$5.9M 0.09%
23,737
+46
+0.2% +$11.3K
ADMA icon
287
ADMA Biologics
ADMA
$2.14B
$5.88M 0.09%
296,442
-9,910
-3% -$171K
NBIX icon
288
Neurocrine Biosciences
NBIX
$16.5B
$5.87M 0.09%
53,103
+6,233
+13% +$790K
IDCC icon
289
InterDigital
IDCC
$8.53B
$5.84M 0.09%
28,268
-3,760
-12% -$757K
NVO
290
Novo Nordisk
NVO
$197B
$5.83M 0.09%
83,980
-15,203
-15% -$1.26M
EVR icon
291
Evercore
EVR
$12.4B
$5.79M 0.09%
28,966
-816
-3% -$203K
STRL icon
292
Sterling Infrastructure
STRL
$17B
$5.72M 0.09%
50,555
-47,391
-48% -$6.67M
ONTO icon
293
Onto Innovation
ONTO
$13.9B
$5.68M 0.09%
46,834
-66,830
-59% -$11.3M
PCVX icon
294
Vaxcyte
PCVX
$7.97B
$5.66M 0.09%
149,762
-4,226
-3% -$338K
ALKT icon
295
Alkami Technology
ALKT
$2.01B
$5.65M 0.09%
215,288
-6,067
-3% -$191K
LNTH icon
296
Lantheus
LNTH
$6.61B
$5.56M 0.09%
+56,942
New +$5.33M
SG icon
297
Sweetgreen
SG
$709M
$5.52M 0.08%
220,652
-6,219
-3% -$172K
LAUR icon
298
Laureate Education
LAUR
$5.26B
$5.47M 0.08%
267,475
-5,556
-2% -$107K
JXN icon
299
Jackson Financial
JXN
$9.38B
$5.46M 0.08%
65,129
-1,395
-2% -$124K
ETN icon
300
Eaton
ETN
$175B
$5.43M 0.08%
19,985
+85
+0.4% +$26.5K

Similar funds

Segall Bryant & Hamill's Q1 2025 Portfolio in Review

As of Q1 2025, Segall Bryant & Hamill held 647 positions worth $6.53B, down 10% from $7.27B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Segall Bryant & Hamill withdrew a net $221M in Q1 2025, closing 74 positions and reducing 319 holdings. Its most notable exit was Summit Materials, Inc. Class A Common Stock, an estimated $77.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.

Against the trend, Segall Bryant & Hamill opened a new position in Synaptics worth $31.8M.

  • Segall Bryant & Hamill's largest Q1 2025 buy was Synaptics: 499,078 shares worth $31.8M.
  • Segall Bryant & Hamill added most to FIVE9 in Q1 2025, an estimated $20.1M increase.
  • Segall Bryant & Hamill's biggest Q1 2025 reduction was VF Corp, cutting an estimated $27.5M.
  • Segall Bryant & Hamill fully exited Summit Materials, Inc. Class A Common Stock in Q1 2025, selling an estimated $77.1M.
  • Segall Bryant & Hamill's ten largest holdings make up 12% of its $6.53B portfolio in Q1 2025.
  • Segall Bryant & Hamill opened 71 new positions and closed 74 in Q1 2025.
  • Segall Bryant & Hamill's portfolio value fell 10% quarter-over-quarter to $6.53B.

Based on Segall Bryant & Hamill's 13F filing for Q1 2025, filed 2 May 2025.